We investigated the effect of saxagliptin in the Saxagliptin Assessment of Vascular Outcomes Recorded in Patients with Diabetes Mellitus ( SAVOR ) - Thrombolysis in Myocardial Infarction ( TIMI ) 53 trial according to baseline renal function .